These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2101907)

  • 1. Switch-function of amino sugar on elsamicin A, a DNA binding antitumor antibiotic.
    Uesugi M; Sugiura Y
    Nucleic Acids Symp Ser; 1990; (22):33-4. PubMed ID: 2101907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective DNA cleavage by elsamicin A and switch function of its amino sugar group.
    Uesugi M; Sekida T; Matsuki S; Sugiura Y
    Biochemistry; 1991 Jul; 30(27):6711-5. PubMed ID: 1648389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of elsamicin-DNA binding specificity by restriction enzyme cleavage.
    Párraga A; Portugal J
    FEBS Lett; 1992 Mar; 300(1):25-9. PubMed ID: 1312486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elsamicin A binding to DNA. A comparative thermodynamic characterization.
    Barceló F; Portugal J
    FEBS Lett; 2004 Oct; 576(1-2):68-72. PubMed ID: 15474012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-unwinding test using eukaryotic DNA topoisomerase I.
    Shen LL
    Methods Mol Biol; 2001; 95():149-60. PubMed ID: 11089228
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of elsamicin A on the activity of mammalian topoisomerase I.
    Rodríguez-Campos A; Azorín F; Portugal J
    Biochemistry; 1996 Aug; 35(34):11177-82. PubMed ID: 8780522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chartreusin, elsamicin A and related anti-cancer antibiotics.
    Portugal J
    Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):411-20. PubMed ID: 14529449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity.
    Konishi M; Sugawara K; Kofu F; Nishiyama Y; Tomita K; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Jun; 39(6):784-91. PubMed ID: 3733527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and modelling studies on the DNA cleavage by elsamicin A.
    Párraga A; Orozco M; Portugal J
    Eur J Biochem; 1992 Sep; 208(2):227-33. PubMed ID: 1325899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics study of the binding of elsamicin A to DNA.
    Alhambra C; Luque FJ; Portugal J; Orozco M
    Eur J Biochem; 1995 Jun; 230(2):555-66. PubMed ID: 7607229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elsamicin A can convert the Z-form of poly[d(G-C)] and poly[(G-m5C)] back to B-form DNA.
    Jiménez-García E; Portugal J
    Biochemistry; 1992 Nov; 31(46):11641-6. PubMed ID: 1445900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Map of chartreusin and elsamicin binding sites on DNA.
    Salas X; Portugal J
    FEBS Lett; 1991 Nov; 292(1-2):223-8. PubMed ID: 1959610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structure elucidation of vicenistatin M, and importance of the vicenisamine aminosugar for exerting cytotoxicity of vicenistatin.
    Matsushima Y; Nakayama T; Fujita M; Bhandari R; Eguchi T; Shindo K; Kakinuma K
    J Antibiot (Tokyo); 2001 Mar; 54(3):211-9. PubMed ID: 11372778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on binding of toromycin, an antitumor antibiotic, to DNA.
    Shishido K; Joho K; Uramoto M; Isono K; Jain T
    Biochem Biophys Res Commun; 1986 May; 136(3):885-90. PubMed ID: 3013173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product analyses in DNA strand scission by antitumor antibiotic elsamicin A.
    Uesugi M; Sugiura Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):580-7. PubMed ID: 1321617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue.
    Bailly C; Qu X; Anizon F; Prudhomme M; Riou JF; Chaires JB
    Mol Pharmacol; 1999 Feb; 55(2):377-85. PubMed ID: 9927631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of DNA-protein interactions in the P1 and P2 c-myc promoters by two intercalating drugs.
    Vaquero A; Portugal J
    Eur J Biochem; 1998 Jan; 251(1-2):435-42. PubMed ID: 9492315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enediyne antibiotics.
    Smith AL; Nicolaou KC
    J Med Chem; 1996 May; 39(11):2103-17. PubMed ID: 8667354
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of actin of gilvocarcin V and chrysomycin A.
    Wei TT; Byrne KM; Warnick-Pickle D; Greenstein M
    J Antibiot (Tokyo); 1982 Apr; 35(4):545-8. PubMed ID: 7096212
    [No Abstract]   [Full Text] [Related]  

  • 20. Acid-promoted DNA-cleaving activities and total synthesis of varacin C.
    Lee AH; Chen J; Liu D; Leung TY; Chan AS; Li T
    J Am Chem Soc; 2002 Nov; 124(47):13972-3. PubMed ID: 12440877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.